What are the major opportunities in the Heplisav-B market? What are the strategies for the Heplisav-B market?

For detailed insights on the major opportunities and strategies in the Heplisav-B market, Read More

How does the Heplisav-B market relate to the overall economy and other similar markets?

For detailed insights on Heplisav-B's relation to the overall economy and other similar markets, Read More

What are the latest mergers and acquisitions in the Heplisav-B industry?

For detailed insights on the mergers and acquisitions in the Heplisav-B industry, Read More

What are the key dynamics influencing the Heplisav-B market growth? SWOT analysis of the Heplisav-B market.

For detailed insights on the key dynamics influencing the Heplisav-B market growth and SWOT analysis of the Heplisav-B industry, Read More

Item added to cart!

Report Price : $4490.00

Pages :

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF

Purchase This Report

Heplisav-B Global Market Report 2025

Name: Heplisav-B Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Product Type (Vaccines, Combination Vaccines), By Indication (Adult Hepatitis B Prevention, Special Populations), By Distribution Channel (Integrated Delivery Networks (IDNs) And Large Clinics, Retail Pharmacies, Hospitals)

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Heplisav-B Market?

Heplisav-B is a recombinant vaccine designed to protect adults aged 18 and older against Hepatitis B. It contains hepatitis B surface antigen (HBsAg) and an advanced adjuvant (1018) to enhance immune response. Administered as a two-dose series over one month, Heplisav-B offers higher seroprotection rates and greater convenience compared to traditional three-dose vaccines, making it particularly effective for high-risk individuals such as healthcare workers, those with chronic liver disease, or people with diabetes.

The main typs of heplisav-B products are vaccines and combination vaccines. Vaccines are biological preparations that provide immunity to a specific infectious disease by stimulating the body's immune system to recognize and fight pathogens. It is used for adult hepatitis b prevention and special populations and is distributed through integrated delivery networks (idns) and large clinics, retail pharmacies, and hospitals.

Heplisav-B Market Size and growth rate 2025 to 2029: Graph

What Is The Heplisav-B Market Size 2025 And Growth Rate?

The heplisav-B market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to a rise in government funding, increased investments in research and development, a rise in the global aging population, government support for immunization programs, and growth in healthcare spending.

What Is The Heplisav-B Market Growth Forecast?

The heplisav-B market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to the increasing prevalence of hepatitis B cases, increasing chronic diseases, growing global health initiatives, rising healthcare costs, and growing healthcare infrastructure. Major trends in the forecast period include technological advancements, rapid vaccination solutions, digital health tools, personalized medicine, and telemedicine.

Book your 30 minutes free consultation with our research experts

How Is The Heplisav-B Market Segmented?

The heplisav-b market covered in this report is segmented –

1) By Product Type: Vaccines, Combination Vaccines

2) By Indication: Adult Hepatitis B Prevention, Special Populations

3) By Distribution Channel: Integrated Delivery Networks (IDNs) And Large Clinics, Retail Pharmacies, Hospitals

What Is Driving The Heplisav-B Market? Rising Prevalence Of Hepatitis B Infections Driving Market Growth

The increasing prevalence of hepatitis B infections is expected to boost the growth of the heplisav-B market going forward. Hepatitis B infections are liver diseases caused by the hepatitis B virus (HBV), which can lead to acute or chronic conditions, including cirrhosis and liver cancer. The prevalence of hepatitis B infections is rising due to low vaccination rates, high-risk group transmission, limited awareness, and inadequate healthcare access. Heplisav-B is a vaccine used to prevent hepatitis B infection by stimulating the immune system to produce protective antibodies. For instance, in April 2024, according to the World Health Organization, a Switzerland-based health authority, an estimated 254 million people globally were affected by chronic hepatitis B in 2022, with 1.2 million new cases reported each year. The disease led to around 1.1 million deaths, largely due to complications such as cirrotic liver disease and liver cancer (hepatocellular carcinoma). Therefore, the increasing prevalence of hepatitis B infections will drive the growth of the heplisav-B market.

What Is Driving The Heplisav-B Market? Impact Of Rising Chronic Disease Prevalence On Market Growth

The rising prevalence of chronic diseases is expected to drive the growth of the heplisav-B market going forward. Chronic disease is a long-term health condition that typically progresses slowly, persists for an extended period, and often requires ongoing medical care and lifestyle management. The rising prevalence of chronic diseases is driven by factors such as aging populations, lifestyle changes, inadequate healthcare access, and increased environmental exposures. Heplisav-b is required for the management of chronic diseases, particularly in individuals with weakened immune systems, as it provides a stronger and longer-lasting immune response to protect against hepatitis B infection. For instance, in December 2023, according to the Australian Bureau of Statistics, an Australia-based government agency, 81.4% of individuals, totaling 20.7 million, indicated that they had at least one long-term health condition lasting six months or longer in 2022, while 49.9% (12.6 million) reported having at least one chronic condition. Women were more likely than men to experience chronic conditions, with 52.3% versus 47.4%. Therefore, the rising prevalence of chronic diseases will drive the growth of the heplisav-B market.

Who Are The Major Players In The Global Heplisav-B Market?

Major companies operating in the heplisav-b market include Dynavax Technologies Corporation

What Are The Key Trends Of The Global Heplisav-B Market? Advancements In Hepatitis B Vaccination

The key trend in the heplisav-B market is focusing on developing innovative products, such as hepatitis b adjuvanted vaccines, to provide stronger and longer-lasting immune responses. A hepatitis B adjuvanted vaccine is an immunization that includes an adjuvant to enhance the body's immune response to the hepatitis B surface antigen, improving vaccine efficacy, especially in populations with weaker immune systems. For instance, in February 2023, Dynavax Technologies Corporation, a US-based biopharmaceutical company, announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) approved Heplisav-B for marketing in Great Britain. This vaccine is designed for adults and is approved for active immunization against all known subtypes of the hepatitis B virus (HBV) in individuals aged 18 years and older. The approval was based on favorable safety and immunogenicity outcomes demonstrated in three Phase 3 clinical trials. Heplisav-B combines the hepatitis B surface antigen with Dynavax's proprietary Toll-like Receptor (TLR) 9 agonist adjuvant, CpG 1018, to enhance the immune response. Dynavax holds the global commercial rights to Heplisav-B.

Need data on a specific region in this market?

Request Regional Data

Regional Analysis For The Global Heplisav-B Market

North America was the largest region in the heplisav-B market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the heplisav-b market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the heplisav-b market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada

What Defines the Heplisav-B Market?

The heplisav-B market consists of sales of adjuvants, immunology products, diagnostic kits, and therapeutic vaccines. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Heplisav-B Industry?

The heplisav-B market research report is one of a series of new reports from The Business Research Company that provides heplisav-B market statistics, including heplisav-B industry global market size, regional shares, competitors with a heplisav-B market share, detailed heplisav-B market segments, market trends and opportunities, and any further data you may need to thrive in the heplisav-B industry. This heplisav-B market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Heplisav-B Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	Included !
Revenue Forecast In 2034	Included !
Growth Rate	Included ?
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Product Type: Vaccines, Combination Vaccines 2) By Indication: Adult Hepatitis B Prevention, Special Populations 3) By Distribution Channel: Integrated Delivery Networks (IDNs) And Large Clinics, Retail Pharmacies, Hospitals
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Dynavax Technologies Corporation
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Heplisav-B Market Characteristics

3. Heplisav-B Market Biologic Drug Characteristics

3.1. Molecule Type

3.2. Route Of Administration (ROA)

3.3. Mechanism Of Action (MOA)

3.4. Safety And Efficacy

4. Heplisav-B Market Trends And Strategies

5. Heplisav-B Market -Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

6. Global Heplisav-B Growth Analysis And Strategic Analysis Framework

6.1. Global Heplisav-B PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

6.2. Analysis Of End Use Industries

6.3. Global Heplisav-B Market Growth Rate Analysis

6.4. Global Heplisav-B Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

6.5. Global Heplisav-B Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

6.6. Global Heplisav-B Total Addressable Market (TAM)

7. Global Heplisav-B Pricing Analysis & Forecasts

8. Heplisav-B Market Segmentation

8.1. Global Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Vaccines

Combination Vaccines

8.2. Global Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Adult Hepatitis B Prevention

Special Populations

8.3. Global Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Integrated Delivery Networks (IDNs) And Large Clinics

Retail Pharmacies

Hospitals

9. Global Heplisav-B Epidemiology Of Clinical Indications

9.1. Drug Side Effects

9.2. Incidence And Prevalence of Clinical Indications

10. Heplisav-B Market Regional And Country Analysis

10.1. Global Heplisav-B Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

10.2. Global Heplisav-B Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11. Asia-Pacific Heplisav-B Market

11.1. Asia-Pacific Heplisav-B Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.3. Asia-Pacific Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.4. Asia-Pacific Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

12. China Heplisav-B Market

12.1. China Heplisav-B Market Overview

12.2. China Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.3. China Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.4. China Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

13. India Heplisav-B Market

13.1. India Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.2. India Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.3. India Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14. Japan Heplisav-B Market

14.1. Japan Heplisav-B Market Overview

14.2. Japan Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.3. Japan Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.4. Japan Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15. Australia Heplisav-B Market

15.1. Australia Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.2. Australia Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.3. Australia Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16. South Korea Heplisav-B Market

16.1. South Korea Heplisav-B Market Overview

16.2. South Korea Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.3. South Korea Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.4. South Korea Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17. Western Europe Heplisav-B Market

17.1. Western Europe Heplisav-B Market Overview

17.2. Western Europe Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.3. Western Europe Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.4. Western Europe Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18. UK Heplisav-B Market

18.1. UK Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.2. UK Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.3. UK Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19. Germany Heplisav-B Market

19.1. Germany Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.2. Germany Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.3. Germany Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20. France Heplisav-B Market

20.1. France Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.2. France Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.3. France Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21. Eastern Europe Heplisav-B Market

21.1. Eastern Europe Heplisav-B Market Overview

21.2. Eastern Europe Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.3. Eastern Europe Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.4. Eastern Europe Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22. North America Heplisav-B Market

22.1. North America Heplisav-B Market Overview

22.2. North America Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.3. North America Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.4. North America Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23. USA Heplisav-B Market

23.1. USA Heplisav-B Market Overview

23.2. USA Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.3. USA Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.4. USA Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24. Canada Heplisav-B Market

24.1. Canada Heplisav-B Market Overview

24.2. Canada Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.3. Canada Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.4. Canada Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25. South America Heplisav-B Market

25.1. South America Heplisav-B Market Overview

25.2. South America Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.3. South America Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.4. South America Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26. Middle East Heplisav-B Market

26.1. Middle East Heplisav-B Market Overview

26.2. Middle East Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.3. Middle East Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.4. Middle East Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27. Africa Heplisav-B Market

27.1. Africa Heplisav-B Market Overview

27.2. Africa Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.3. Africa Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.4. Africa Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

28. Heplisav-B Market Competitive Landscape And Company Profiles

28.1. Heplisav-B Market Competitive Landscape

28.2. Heplisav-B Market Company Profiles

28.2.1. Dynavax Technologies Corporation Overview, Products and Services, Strategy and Financial Analysis

29. Global Heplisav-B Market Pipeline Analysis

29.1. High Level Clinic Trail Information

30. Global Heplisav-B Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Heplisav-B Market

32. Recent Developments In The Heplisav-B Market

33. Heplisav-B Market High Potential Countries, Segments and Strategies

33.1 Heplisav-B Market In 2029 - Countries Offering Most New Opportunities

33.2 Heplisav-B Market In 2029 - Segments Offering Most New Opportunities

33.3 Heplisav-B Market In 2029 - Growth Strategies

33.3.1 Market Trend Based Strategies

33.3.2 Competitor Strategies

34. Appendix

34.1. Abbreviations

34.2. Currencies

34.3. Historic And Forecast Inflation Rates

34.4. Research Inquiries

34.5. The Business Research Company

34.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Million

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million

Table 3: Global Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 4: Global Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 5: Global Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 6: Global Heplisav-B Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 7: Global Heplisav-B Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 8: Asia-Pacific, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 9: Asia-Pacific, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 10: Asia-Pacific, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 11: China, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 12: China, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 13: China, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 14: India, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 15: India, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 16: India, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 17: Japan, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 18: Japan, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 19: Japan, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 20: Australia, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 21: Australia, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 22: Australia, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 23: South Korea, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 24: South Korea, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 25: South Korea, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 26: Western Europe, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 27: Western Europe, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 28: Western Europe, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 29: UK, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 30: UK, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 31: UK, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 32: Germany, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 33: Germany, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 34: Germany, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 35: France, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 36: France, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 37: France, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 38: Eastern Europe, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 39: Eastern Europe, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 40: Eastern Europe, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 41: North America, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 42: North America, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 43: North America, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 44: USA, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 45: USA, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 46: USA, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 47: Canada, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 48: Canada, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 49: Canada, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 50: South America, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 51: South America, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 52: South America, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 53: Middle East, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 54: Middle East, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 55: Middle East, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 56: Africa, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 57: Africa, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 58: Africa, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 59: Dynavax Technologies Corporation Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Million

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million

Figure 3: Global Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 4: Global Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 5: Global Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 6: Global Heplisav-B Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 7: Global Heplisav-B Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 8: Asia-Pacific, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 9: Asia-Pacific, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 10: Asia-Pacific, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 11: China, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 12: China, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 13: China, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 14: India, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 15: India, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 16: India, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 17: Japan, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 18: Japan, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 19: Japan, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 20: Australia, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 21: Australia, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 22: Australia, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 23: South Korea, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 24: South Korea, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 25: South Korea, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 26: Western Europe, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 27: Western Europe, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 28: Western Europe, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 29: UK, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 30: UK, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 31: UK, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 32: Germany, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 33: Germany, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 34: Germany, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 35: France, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 36: France, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 37: France, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 38: Eastern Europe, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 39: Eastern Europe, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 40: Eastern Europe, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 41: North America, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 42: North America, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 43: North America, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 44: USA, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 45: USA, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 46: USA, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 47: Canada, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 48: Canada, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 49: Canada, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 50: South America, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 51: South America, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 52: South America, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 53: Middle East, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 54: Middle East, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 55: Middle East, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 56: Africa, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 57: Africa, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 58: Africa, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 59: Dynavax Technologies Corporation Financial Performance

Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor Market Outlook 2025: Mapping Growth, Innovation, and Regional Shifts

Global Vutrisiran Market Trends: Regional Breakdowns and Strategic Insights

Vyndaqel Outlook 2034: Key Drivers, Trends, and Market Frontiers

Functional Dyspepsia DrugMarket Overview 2025–2034: CAGR Trends, Long-Term Growth Paths, and Business Implications

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By ...

Pharmaceutical Drugs Market 2024 – By Type (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorde...

Oncology Drugs Market 2023 – By Type (Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Ca...

Dry Eye Medication Market 2021 - By Prescription Type (OTC Drugs, Prescription Drugs) By Drug Variation (Branded, Generic) By Type Of Product (Aqueous, Evaporative, Aqueous And Evaporative) By Distribution Channel (Hospi...

Oncology Drugs Global Market Report 2022 – By Type (Lung Cancer Drugs, Pancreatic Cancer Drugs, Breast Cancer Drugs, Prostate Cancer Drugs, Ovarian Cancer Drugs, Colorectal Cancer Drugs, Gastric Cancer Drugs, Kidney Canc...

Ophthalmology Drugs Global Market Report 2022 – By Type (Antiglaucoma Drugs, Dry Eye Medication, Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)), By Distribution Channel (Hospital Pharmacies, R...

Cardiovascular Drugs Global Market Report 2022 – By Type (Anti-Hypertensive Drugs, Hypolipidemics, Anti Thrombotics, Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrhythmic And Anti-Anginal Dru...

Frequently Asked Questions

What is the definition of the Heplisav-B market?

Heplisav-B is a recombinant vaccine designed to protect adults aged 18 and older against hepatitis B. It contains hepatitis B surface antigen (HBsAg) and an advanced adjuvant (1018) to enhance immune response. Administered as a two-dose series over one month, Heplisav-B offers higher seroprotection rates and greater convenience compared to traditional three-dose vaccines, making it particularly effective for high-risk individuals such as healthcare workers, those with chronic liver disease, or people with diabetes. For further insights on the Heplisav-B market, request a sample here

How will the Heplisav-B market drivers and restraints affect the market dynamics? What forces will shape the Heplisav-B industry going forward?

The Heplisav-B market major growth driver - Rising Prevalence Of Hepatitis B Infections Driving Market Growth. For further insights on the Heplisav-B market, request a sample here

What is the forecast market size or the forecast market value of the Heplisav-B market?

The Heplisav-B market size has grown strongly in recent years. The heplisav-B market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to a rise in government funding, increased investments in research and development, a rise in the global aging population, government support for immunization programs, and growth in healthcare spending. The heplisav-B market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to the increasing prevalence of hepatitis B cases, increasing chronic diseases, growing global health initiatives, rising healthcare costs, and growing healthcare infrastructure. Major trends in the forecast period include technological advancements, rapid vaccination solutions, digital health tools, personalized medicine, and telemedicine. For further insights on the Heplisav-B market, request a sample here

How is the Heplisav-B market segmented?

The heplisav-b market covered in this report is segmented –
1) By Product Type: Vaccines, Combination Vaccines
2) By Indication: Adult Hepatitis B Prevention, Special Populations
3) By Distribution Channel: Integrated Delivery Networks (IDNs) And Large Clinics, Retail Pharmacies, Hospitals For further insights on the Heplisav-B market, request a sample here

Which region has the largest share of the Heplisav-B market? What are the other regions covered in the report?

Who are the major players in the Heplisav-B market?

Major companies operating in the heplisav-b market include Dynavax Technologies Corporation . For further insights on the Heplisav-B market, request a sample here.

What are the key trends in the Heplisav-B market?

Major trends in the Heplisav-B market include Advancements In Hepatitis B Vaccination. For further insights on the Heplisav-B market, request a sample here.